Published in Mol Biol Cell on February 04, 2009
Defining the molecular character of the developing and adult kidney podocyte. PLoS One (2011) 1.29
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A (2012) 0.96
raw Functions through JNK signaling and cadherin-based adhesion to regulate Drosophila gonad morphogenesis. Dev Biol (2012) 0.85
MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget (2016) 0.81
Impact of p120-catenin isoforms 1A and 3A on epithelial mesenchymal transition of lung cancer cells expressing E-cadherin in different subcellular locations. PLoS One (2014) 0.80
Cap-Independent Translational Control of Carcinogenesis. Front Oncol (2016) 0.79
A central role for cadherin signaling in cancer. Exp Cell Res (2017) 0.75
Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling. J Cell Biol (2017) 0.75
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell (2001) 10.02
AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer (2003) 8.88
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell (1994) 8.65
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature (1998) 8.48
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer (2004) 6.73
Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol (1989) 6.31
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta (1994) 5.81
Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (1988) 5.18
Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol (1998) 4.43
Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem (2003) 4.33
Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell (2003) 3.92
Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science (1997) 3.11
Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol (2003) 3.09
Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature (2005) 3.05
Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A (1999) 2.43
c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol (1994) 2.41
Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis. J Biol Chem (1987) 2.36
Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem (2000) 2.12
Translational initiation factor and ribosome association with the cytoskeletal framework fraction from HeLa cells. Cell (1984) 2.08
Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell (2007) 2.03
Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp Cell Res (1996) 1.60
Genome-wide analysis demonstrates conserved localization of messenger RNAs to mitotic microtubules. J Cell Biol (2007) 1.55
Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res (2003) 1.51
AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol Cell Biol (1997) 1.46
Stress-activated protein kinases are negatively regulated by cell density. EMBO J (1998) 1.43
Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev (1998) 1.42
Microtubule disruption stimulates P-body formation. RNA (2007) 1.35
A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog (1997) 1.27
Polyribosome targeting to microtubules: enrichment of specific mRNAs in a reconstituted microtubule preparation from sea urchin embryos. J Cell Biol (1994) 1.06
Both the dimerization and immunochemical properties of E-cadherin EC1 domain depend on Trp(156) residue. Arch Biochem Biophys (2002) 1.03
Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner. Oncogene (2008) 1.02
Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. Mol Biol Cell (2001) 0.99
Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. Mol Cell Biol (2004) 0.94
Microtubules, ribosomes, and RNA: evidence for cytoplasmic localization and translational regulation. Cell Motil Cytoskeleton (1993) 0.92
The chicken c-Jun 5' untranslated region directs translation by internal initiation. Oncogene (2000) 0.87
The cytoskeletal network controls c-Jun expression and glucocorticoid receptor transcriptional activity in an antagonistic and cell-type-specific manner. Mol Cell Biol (1999) 0.87
The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene (2006) 0.86
Cell to cell contacts control the transcription activity of the glucocorticoid receptor. Mol Endocrinol (1994) 0.84
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology (2003) 2.40
miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol (2009) 2.06
Efficient transfection method for primary cells. Tissue Eng (2002) 1.74
A single flavoprotein, AppA, integrates both redox and light signals in Rhodobacter sphaeroides. Mol Microbiol (2002) 1.63
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med (2009) 1.59
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol (2009) 1.54
Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int J Mol Med (2011) 1.49
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene (2005) 1.41
Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis (2006) 1.29
Snail-regulated genes in malignant melanoma. Melanoma Res (2005) 1.17
Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol (2003) 1.17
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep (2006) 1.14
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res (2009) 1.04
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). Am J Pathol (2011) 1.04
Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res (2005) 1.04
Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res (2007) 1.03
Functional implication of Netrin expression in malignant melanoma. Cell Oncol (2009) 1.02
Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of malignant melanoma. J Cell Biochem (2009) 0.99
Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark (2007) 0.98
Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development. FEBS J (2009) 0.96
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A (2012) 0.96
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis (2013) 0.95
Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders. PLoS One (2013) 0.95
Reduced expression of TANGO in colon and hepatocellular carcinomas. Oncol Rep (2007) 0.93
Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions. J Dermatol Sci (2013) 0.93
Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int (2004) 0.91
Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res (2007) 0.91
Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol (2012) 0.91
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol (2010) 0.91
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch (2014) 0.91
Dual role of NRSF/REST in activation and repression of the glucocorticoid response. J Biol Chem (2007) 0.90
Functional role of MIA in melanocytes and early development of melanoma. Oncogene (2004) 0.90
ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer (2011) 0.90
Induction of Raf kinase inhibitor protein contributes to macrophage differentiation. Biochem Biophys Res Commun (2006) 0.90
Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem Biophys Res Commun (2006) 0.89
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther (2005) 0.89
Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci (2013) 0.89
Expression of integrin alpha10 is induced in malignant melanoma. Cell Oncol (2007) 0.88
TANGO is a tumor suppressor of malignant melanoma. Int J Cancer (2006) 0.88
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells. Lab Invest (2012) 0.88
MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop. Exp Dermatol (2012) 0.88
miR(acle)s - new players in the regulation of known suspects. Pigment Cell Melanoma Res (2009) 0.88
Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J Neurochem (2002) 0.87
Weak mitochondrial targeting sequence determines tissue-specific subcellular localization of glutamine synthetase in liver and brain cells. J Cell Sci (2010) 0.86
The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J (2009) 0.86
Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther (2010) 0.85
Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1. Biochem Biophys Res Commun (2006) 0.85
Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma. Exp Mol Pathol (2013) 0.84
Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.84
BAP1 germline mutation in two first grade family members with uveal melanoma. Br J Ophthalmol (2013) 0.84
Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling. Mol Cell Biol (2012) 0.83
Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol (2006) 0.83
Loss of nephronectin promotes tumor progression in malignant melanoma. Cancer Sci (2008) 0.83
Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. J Chromatogr A (2010) 0.82
Annexin A5 is involved in migration and invasion of oral carcinoma. Cell Cycle (2009) 0.82
Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer (2009) 0.82
Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res (2011) 0.81
Cytoskeletal and cell contact control of the glucocorticoid pathway. Mol Cell Endocrinol (2006) 0.81
Meeting report from the 2011 International Melanoma Congress, Tampa, Florida. Pigment Cell Melanoma Res (2011) 0.81
Fragments of SLIT3 inhibit cellular migration. Int J Mol Med (2012) 0.80
WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis. EMBO Mol Med (2012) 0.80
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells. Cancer Cell Int (2005) 0.80
Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma. Mol Carcinog (2013) 0.80
Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res (2002) 0.79
Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep (2012) 0.79
Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma. Int J Oncol (2004) 0.78
Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma. Exp Dermatol (2011) 0.77
N-cadherin promoter polymorphisms and risk of osteoarthritis. FASEB J (2013) 0.77
The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1). FEBS J (2013) 0.76
A single glutamine synthetase gene produces tissue-specific subcellular localization by alternative splicing. FEBS Lett (2005) 0.76
In vitro behavior of a porous TiO2/perlite composite and its surface modification with fibronectin. Biomaterials (2005) 0.75
Correlation of a novel matrix protein with the degree of cartilage degradation. Rheumatol Int (2002) 0.75
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations. Pigment Cell Melanoma Res (2014) 0.75